Michael Jordan Friedman - 17 Dec 2024 Form 4 Insider Report for INNOVATIVE MEDTECH, INC. (IMTH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
07 Jan 2025, 17:00:07 UTC
Prior SEC filing
17 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Friedman

Key filing fact

Michael Jordan Friedman filed Form 4 for INNOVATIVE MEDTECH, INC. (IMTH) on 07 Jan 2025.

Key facts

  • This page summarizes Michael Jordan Friedman's Form 4 filing for INNOVATIVE MEDTECH, INC. (IMTH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Jan 2025, 17:00.

Change

  • Previous filing in this sequence was filed on 17 Jan 2024.
  • Current net transaction value: +$32,500.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMTH transaction

Common Stock

Other

Transaction value
$32,500
Shares
+6,500,000
Change %
+190%
Price
$0.005000
Shares after
9,918,607
Date
17 Dec 2024
Ownership
By Red Halo, LLC
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

6,500,000 common shares issued in satisfaction of accrued salary of $325,000.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .